Preventive Medicine Foundation is a non-governmental, non-political, and not-for-profit organization. It was established in 1987. We have provided External Quality Assurance ( EQA ) programs for clinical laboratories and newborn screening centers since 1988, including EQA programs for Glucose-6-Phosphate Dehydrogenase Deficiency ( G6PD ) quantitative test, G6PD screening test, and congenital hypothyroidism confirmatory tests. In addition to EQA programs, we started to provide G6PD Internal Quality Control ( IQC ) programs in 2008. More than 90 international newborn screening centers and clinical laboratories ( from 14 countries ) have participated in our EQA and/or IQC programs at present time.

We are a member of Clinical and Laboratory Standards Institute ( CLSI ) and  European organization for External Quality Assurance Providers in Laboratory Medicine ( EQALM ).

Accredited to ISO/IEC 17043

Latest News

2024-03-13
Reports of EQA Survey
2024 1^st Run

for Neonatal G6PD Screening Test ( Survey No.：NS2024-01 )

for Neonatal G6PD Quantitative Test in Taiwan ( Survey No.：RH2024-01 ) ( IMP_S2 ) ( PDF_Chinese version )

for Neonatal G6PD Quantitative Test in Philippines ( Survey No.：RH2024-01 ) ( PDF )

 

2023-09-19
Reports of EQA Survey
2023 3^rd Run

for Neonatal G6PD Screening Test ( Survey No.：NS2023-03 )

for Neonatal G6PD Quantitative Test in Taiwan ( Survey No.：RH2023-03 ) ( IMP_S1 ) ( IMP_S3 ) ( PDF_Chinese version )

for Neonatal G6PD Quantitative Test in Philippines ( Survey No.：RH2023-03 ) ( PDF )